期刊
INTERNAL MEDICINE JOURNAL
卷 44, 期 3, 页码 287-290出版社
WILEY
DOI: 10.1111/imj.12363
关键词
immunosuppression; biologicals; psoriasis; hepatosplenic T-cell lymphoma; inflammatory bowel disease
We present three cases of the rare hepatosplenic T-cell lymphoma (HSTCL); two patients suffering from Crohn disease who developed HSTCL on azathioprine without exposure to biologicals, and a third patient who had psoriasis treated using etanercept, cyclosporine and methotrexate. The evidence for an association between HSTCL and immunosuppressive drugs and biologicals is reviewed. We argue for improved pharmacovigilance processes to help determine the benefit to risk ratios for the use of these and other new agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据